Back in 2017, a study was published on the Annals of Internal Medicine. In it were compelling findings regarding the life expectancy of the average individual living with cystic fibrosis. The data collected from researchers indicates that those living in Canada are likelier to live over a decade longer than those in the United States.
These findings are important in 2021 because, as highlighted by the current pandemic we’re enduring, healthcare efficiency is crucial. Combined with fewer paywalls for patients to deal with and a lower overall population, Canada is positioned to maintain this trend. Today, let’s dig into the specifics of the study in more detail.
Availability of Care and Dietary Standards Make a Difference
This population-based study, consisting of over 42 Canadian and 110 American cystic fibrosis care facilities, respectively, revealed a myriad of variables which caregivers must contend with. Symptom intensity, lung transplantation potentialities, pre-existing health conditions worsening outlook and otherwise are factored into the findings, and so is the availability of care to the patient. In the end, unless you have private insurance to cover the expenses of appropriate treatment, your lifespan in the United States with cystic fibrosis is considerably less than if you sought care as a Canadian citizen or permanent resident.
In addition, recommended diets for patients in Canada consist of more nutritional alternatives, and there’s no question that high-fat, high-calorie foods can have an otherwise negative impact on health. The former wasn’t adopted in the U.S. for nearly a decade. Even without a transplant, if your diet is optimal, you have every chance of outliving the American lifespan estimate.
Discussions of Pricing and Practicality
Our healthcare system is vastly unique from that of any state. Patients don’t need to pay for much else other than additional tests, prescriptions and the like – there’s no sticker shock for an emergency transplant to worry about. In addition, our operational processes are set up in a way that could possibly be more efficient, even when we’re desperately in need of more doctors, nurses and other healthcare staff to meet consistently high demand. The differential access to transplantation, as termed in the study, could possibly explain the increased life expectancy north of the border. We at Qualicare Waterloo are firm believers in compassionate care, and with that compassion comes a dedication to keeping appropriate treatment solutions within arms’ reach of any household. In addition, nearly 4 percent more patients in Canada compared to the U.S. were able to secure transplants, which contributed towards the higher estimated lifespan here.
If you’re interested in learning more about cystic fibrosis treatment solutions in Canada, or what our compassionate caregiving team can do, feel free to reach out to us. At Qualicare Waterloo, we’re here to put your peace of mind and health first in any way we can.
Comments are closed.